Company intelligence / Profile preview

Livzon Pharmaceutical Group Inc.

Zhuhai, Guangdong, Chinaen.livzon.com.cn ↗
Ownership
Public · 000513
Employees
~9067
Development stage
Commercial
01

Overview

Livzon has a broad commercial portfolio with over eighty marketed products across multiple therapeutic areas. Its pipeline includes more than twenty programs in various stages of development. Notably, it developed a recombinant SARS-CoV-2 fusion protein vaccine that has been deployed regionally in China. The company continues to expand its oncology pipeline through partnerships such as the TYK Medicines collaboration for multi-targeted kinase inhibitors targeting resistance mutations in cancer patients

Therapeutic areas
OncologyMetabolic DisordersEndocrinologyPsychiatryGastroenterologyInfectious Diseases
Modalities
Small moleculesbiologics (including antibody medicines and vaccines)diagnostic reagentsAPIspolypeptides
Industry
Biotech
02

Drug pipeline

1 asset

LZM004

Unknown
03

Partnerships

TYK Medicines – collaboration on multi-targeted kinase inhibitors for oncology indications in Greater ChinaShanghai Synergy Pharma Sciences – acquisition of HHT‑120 Project

Beyond the preview

Go deeper on Livzon Pharmaceutical Group Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Livzon Pharmaceutical Group Inc..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call